Bastadins-6, -9 and -16 isolated from the marine sponge Ianthella basta displayed in vitro cytostatic and/or cytotoxic effects in six human and mouse cancer cell lines. The in vitro growth inhibitory effects of these bastadins were similar in cancer cell lines sensitive to pro-apoptotic stimuli versus cancer cell lines displaying various levels of resistance to pro-apoptotic stimuli. While about ten times less toxic than the natural cyclic bastadins, the synthetically derived 5,5'-dibromohemibastadin-1 (DBHB) displayed not only in vitro growth inhibitory activity in cancer cells but also anti-angiogenic properties. At a concentration of one tenth of its in vitro growth inhibitory concentration, DBHB displayed actual antimigratory effects in mouse B16F10 melanoma cells without any sign of cytotoxicity and/or growth inhibition. The serum concentration used in the cell culture media markedly influenced the DBHB-induced antimigratory effects in the B16F10 melanoma cell population. We are currently developing a specific inhalation formulation for DBHB enabling this compound to avoid plasmatic albumin binding through its direct delivery to the lungs to combat primary as well as secondary (metastases) tumors.
从海洋海绵 Ianthella basta 中分离出的 Bastadins-6、-9 和 -16 对六种人类和小鼠癌细胞株具有体外细胞抑制和/或细胞毒性作用。在对促凋亡刺激敏感的癌
细胞系和对促凋亡刺激有不同程度抵抗力的癌
细胞系中,这些韧皮部蛋白的体外生长抑制作用相似。合成的 5,5'-二
溴半胱
氨酸-1(DBHB)的毒性比天然环状韧皮部素低十倍左右,它不仅具有体外抑制癌细胞生长的活性,还具有抗血管生成的特性。当浓度为体外生长抑制浓度的十分之一时,DBHB 在小鼠 B16F10
黑色素瘤细胞中显示出实际的抗移行作用,而没有任何细胞毒性和/或生长抑制的迹象。
细胞培养基中使用的血清浓度明显影响 DBHB 在 B16F10
黑色素瘤细胞群中诱导的抗移行效应。我们目前正在开发 DBHB 的特殊吸入配方,使这种化合物能够通过直接输送到肺部来避免血浆白蛋白的结合,从而对抗原发性和继发性(转移)肿瘤。